Mechanisms and Active Compounds Polysaccharides and Bibenzyls of Medicinal Dendrobiums for Diabetes Management.
Full text not available from this repository.Item Type: | Review |
---|---|
Status: | Published |
Official URL: | https://doi.org/10.3389/fnut.2021.811870 |
Journal or Publication Title: | Frontiers in Nutrition |
Volume: | 8 |
Date: | 28 January 2022 |
Divisions: | Lipid Cell Biology |
Depositing User: | General Admin |
Identification Number: | 10.3389/fnut.2021.811870 |
ISSN: | 2296-861X |
Date Deposited: | 25 Sep 2022 23:33 |
Abstract: | Background: Medicinal dendrobiums are used popularly in traditional Chinese medicine for the treatment of diabetes, while their active compounds and mechanism remain unclear. This review aimed to evaluate the mechanism and active compounds of medicinal dendrobiums in diabetes management through a systematic approach. Methods: A systematic approach was conducted to search for the mechanism and active phytochemicals in Dendrobium responsible for anti-diabetic actions using databases PubMed, Embase, and SciFinder. Results: Current literature indicates polysaccharides, bibenzyls, phenanthrene, and alkaloids are commonly isolated in Dendrobium genusin which polysaccharides and bibenzyls are most aboundant. Many animal studies have shown that polysaccharides from the species of Dendrobium provide with antidiabetic effects by lowering glucose level and reversing chronic inflammation of T2DM taken orally at 200 mg/kg. Dendrobium polysaccharides protect pancreatic β-cell dysfunction and insulin resistance in liver. Dendrobium polysaccharides up-regulate the abundance of short-chain fatty acid to stimulate GLP-1 secretion through gut microbiota. Bibenzyls also have great potency to inhibit the progression of the chronic inflammation in cellular studies. Conclusion: Polysaccharides and bibenzyls are the major active compounds in medicinal dendrobiums for diabetic management through the mechanisms of lowering glucose level and reversing chronic inflammation of T2DM by modulating pancreatic β-cell dysfunction and insulin resistance in liver as a result from gut microbita regulation. |
Creators: | Creators Email Li, Mingjian UNSPECIFIED Trapika, I. Gusti Surya Chandra UNSPECIFIED Tang, Suet Yee Sara UNSPECIFIED Cho, Jun-Lae UNSPECIFIED Qi, Yanfei UNSPECIFIED Li, Chun Guang UNSPECIFIED Li, Yujuan UNSPECIFIED Yao, Meicun UNSPECIFIED Yang, Depo UNSPECIFIED Liu, Bowen UNSPECIFIED Li, Rong UNSPECIFIED Yang, Ping UNSPECIFIED Ma, Guoyi UNSPECIFIED Ren, Ping UNSPECIFIED Huang, Xi UNSPECIFIED Xie, Deshan UNSPECIFIED Chen, Shaochao UNSPECIFIED Li, Min UNSPECIFIED Yang, Lan UNSPECIFIED Leng, Ping UNSPECIFIED Huang, Yong UNSPECIFIED Li, George Q. UNSPECIFIED |
Last Modified: | 25 Sep 2022 23:33 |
URI: | https://eprints.centenary.org.au/id/eprint/1242 |
Actions (login required)
![]() |
View Item |